These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 24530366)
21. A novel tri-functional antibody fusion protein with improved pharmacokinetic properties generated by fusing a bispecific single-chain diabody with an albumin-binding domain from streptococcal protein G. Stork R; Müller D; Kontermann RE Protein Eng Des Sel; 2007 Nov; 20(11):569-76. PubMed ID: 17982179 [TBL] [Abstract][Full Text] [Related]
22. Homogeneous tumor targeting with a single dose of HER2-targeted albumin-binding domain-fused nanobody-drug conjugates results in long-lasting tumor remission in mice. Xenaki KT; Dorrestijn B; Muns JA; Adamzek K; Doulkeridou S; Houthoff H; Oliveira S; van Bergen En Henegouwen PM Theranostics; 2021; 11(11):5525-5538. PubMed ID: 33859761 [No Abstract] [Full Text] [Related]
23. Anti-idiotypic nanobody as citrinin mimotope from a naive alpaca heavy chain single domain antibody library. Xu Y; Xiong L; Li Y; Xiong Y; Tu Z; Fu J; Chen B Anal Bioanal Chem; 2015 Jul; 407(18):5333-41. PubMed ID: 25910884 [TBL] [Abstract][Full Text] [Related]
24. The effects of affinity and valency of an albumin-binding domain (ABD) on the half-life of a single-chain diabody-ABD fusion protein. Hopp J; Hornig N; Zettlitz KA; Schwarz A; Fuss N; Müller D; Kontermann RE Protein Eng Des Sel; 2010 Nov; 23(11):827-34. PubMed ID: 20817756 [TBL] [Abstract][Full Text] [Related]
25. Lyophilization of NOTA-sdAbs: First step towards a cold diagnostic kit for Baudhuin H; Van Bockstal PJ; De Beer T; Vaneycken I; Bridoux J; Raes G; Caveliers V; Keyaerts M; Devoogdt N; Lahoutte T; Xavier C Eur J Pharm Biopharm; 2021 Sep; 166():194-204. PubMed ID: 34186190 [TBL] [Abstract][Full Text] [Related]
26. Superior serum half life of albumin tagged TNF ligands. Müller N; Schneider B; Pfizenmaier K; Wajant H Biochem Biophys Res Commun; 2010 Jun; 396(4):793-9. PubMed ID: 20447380 [TBL] [Abstract][Full Text] [Related]
27. Functional mutations in and characterization of VHH against Helicobacter pylori urease. Hoseinpoor R; Mousavi Gargari SL; Rasooli I; Rajabibazl M; Shahi B Appl Biochem Biotechnol; 2014 Mar; 172(6):3079-91. PubMed ID: 24492955 [TBL] [Abstract][Full Text] [Related]
28. In vivo imaging of folate receptor positive tumor xenografts using novel 68Ga-NODAGA-folate conjugates. Fani M; Tamma ML; Nicolas GP; Lasri E; Medina C; Raynal I; Port M; Weber WA; Maecke HR Mol Pharm; 2012 May; 9(5):1136-45. PubMed ID: 22497506 [TBL] [Abstract][Full Text] [Related]
29. Protective effect of different anti-rabies virus VHH constructs against rabies disease in mice. Terryn S; Francart A; Lamoral S; Hultberg A; Rommelaere H; Wittelsberger A; Callewaert F; Stohr T; Meerschaert K; Ottevaere I; Stortelers C; Vanlandschoot P; Kalai M; Van Gucht S PLoS One; 2014; 9(10):e109367. PubMed ID: 25347556 [TBL] [Abstract][Full Text] [Related]
30. Preparation and preliminary bioevaluation studies of Suman SK; Kameswaran M; Pandey U; Sarma HD; Dash A J Labelled Comp Radiopharm; 2019 Oct; 62(12):850-859. PubMed ID: 31461549 [TBL] [Abstract][Full Text] [Related]
31. An anti-TNFR1 scFv-HSA fusion protein as selective antagonist of TNF action. Berger V; Richter F; Zettlitz K; Unverdorben F; Scheurich P; Herrmann A; Pfizenmaier K; Kontermann RE Protein Eng Des Sel; 2013 Oct; 26(10):581-7. PubMed ID: 24006371 [TBL] [Abstract][Full Text] [Related]
32. High production of llama variable heavy-chain antibody fragment (VHH) fused to various reader proteins by Aspergillus oryzae. Hisada H; Tsutsumi H; Ishida H; Hata Y Appl Microbiol Biotechnol; 2013 Jan; 97(2):761-6. PubMed ID: 22752366 [TBL] [Abstract][Full Text] [Related]
33. Improved functional immobilization of llama single-domain antibody fragments to polystyrene surfaces using small peptides. Harmsen MM; Fijten HP J Immunoassay Immunochem; 2012; 33(3):234-51. PubMed ID: 22738648 [TBL] [Abstract][Full Text] [Related]
34. [Preparation and property study of the recombinant Camel anti-SpaA-N single domain antibodies]. Lu QX; Qing GL; Yang CJ; Xia XQ; Li JW Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Jan; 28(1):55-8. PubMed ID: 22230504 [TBL] [Abstract][Full Text] [Related]
35. Head-to-tail fusions of camelid antibodies can be expressed in planta and bind in rumen fluid. Winichayakul S; Pernthaner A; Scott R; Vlaming R; Roberts N Biotechnol Appl Biochem; 2009 Jun; 53(Pt 2):111-22. PubMed ID: 18844608 [TBL] [Abstract][Full Text] [Related]
36. Site-specific Dewulf J; Flieswasser T; Delahaye T; Vangestel C; Miranda A; de Haard H; Jacobs J; Smits E; Van den Wyngaert T; Elvas F EJNMMI Radiopharm Chem; 2023 Apr; 8(1):8. PubMed ID: 37093350 [TBL] [Abstract][Full Text] [Related]
37. Half-life extension of a single-chain diabody by fusion to domain B of staphylococcal protein A. Unverdorben F; Färber-Schwarz A; Richter F; Hutt M; Kontermann RE Protein Eng Des Sel; 2012 Feb; 25(2):81-8. PubMed ID: 22238430 [TBL] [Abstract][Full Text] [Related]
39. PCR-based approach for site-specific conjugation of long double-stranded DNA to a single-domain VHH antibody. Akazawa-Ogawa Y; Komatsu Y; Nakajima Y; Kojima N; Hagihara Y J Biochem; 2020 Jul; 168(1):63-72. PubMed ID: 32154894 [TBL] [Abstract][Full Text] [Related]
40. Half-Life Extension and Biodistribution Modulation of Biotherapeutics via Red Blood Cell Hitch-Hiking with Novel Anti-Band 3 Single-Domain Antibodies. Nguyen TD; Bordeau BM; Zhang Y; Mattle AG; Balthasar JP Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613917 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]